Similarly, genetic abrogation of TGF-β signaling by Smad3 knockout was found to be insufficient to prevent proteinuria in a streptozotocin (STZ)-induced diabetic nephropathy model, despite significant protection from glomerular hypertrophy and GBM thickening [45]. This evidence concerns the gene SMAD3 and diabetic kidney disease.